Noubar Afeyan has told Armen Sarkissian that the company has got the interim data for the first phase of work and the first testing has been successful, said the Armenian presidential press service.

Moderna announced on May 18 that it was launching phase 1 of the vaccine testing.   

In particular, it involved 45 volunteers, in all of whom the vaccination elicited antibodies.

The volunteers, divided into groups by 15, received doses of 25mg, 100mg and 250mg once in 28 days.

Previously, Noubar Afeyan announced that the clinical trial of the COVID-19 vaccine, involving 600 people, would begin in July.